Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Researchers have created a novel immunotherapy for metastatic kidney most cancers that would present a brand new therapy choice for sufferers with restricted...
For sufferers with superior GIST Gleevec, full surgical elimination of metastasis and full Gleevec response are related to survival time doubling.Amongst sufferers with...
Bob Lane, a prostate most cancers survivor, discusses the stigma males typically really feel when speaking about prostate most cancers.Bob Lane, a prostate...
